Related Experiment Videos
Epidermal growth factor receptor inhibitors: a moving target?
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Conflicts of interest and interpretive authority in oncology.
European journal of cancer (Oxford, England : 1990)·2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
FDA Approval Summary: Erdafitinib for FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
DNMT3B plays antagonistic roles with SMARCB1 and is a targetable vulnerability in rhabdoid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
FDA Approval Summary: Retifanlimab for the treatment of adult patients with metastatic or inoperable locally recurrent squamous cell carcinoma of the anal canal.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026